ValuentumAd

Official PayPal Seal

Hedge Fund Manager Bets Big on Health Insurers

publication date: Aug 16, 2012
 | 
author/source: RJ Towner

David Einhorn, manager of hedge fund Greenlight Capital, reported several new positions in health care during the second quarter according to his 13F filling. Einhorn, who we respect for several of his great calls, including Apple (click ticker for report: AAPL) and Seagate Technologies (STX) on the long side and Green Mountain Coffee Roasters (click ticker for report: GMCR) and First Solar (FSLR) on the short side, likely began accumulating a position in response to clarity on the Affordable Healthcare Act, in our view.

The famed hedge fund manager took positions in WellPoint (WLP), Humana (HUM), Coventry (CVH), UnitedHealth Group (UNH), Aetna (AET) and Cigna (CI)—essentially investing in the entire cohort. Most of these companies trade at single digits earnings multiples and generate solid free cash flow.

We prefer to obtain exposure to the healthcare sector via the Healthcare Select Sector SPDR (click ticker for report: XLV). This ETF has a good expense ratio (just 0.18%), excellent Valuentum Buying Index rating, as well as exposure to many of the undervalued firms that have found their way into hedge fund managers' portfolios recently. Diversified exposure, which comes with owning this ETF, also allows us to capitalize on the secular growth of health-care spending, while limiting firm-specific risk due to policy overhaul.


--------------------------------------------------
The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor, and does not offer brokerage or investment banking services. The sources of the data used on this website and reports are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum, its employees, independent contractors and affiliates may have long, short or derivative positions in the securities mentioned on this website. The High Yield Dividend Newsletter portfolio, Best Ideas Newsletter portfolio and Dividend Growth Newsletter portfolio are not real money portfolios. Performance, including that in the Nelson Exclusive publication, is hypothetical and does not represent actual trading. Actual results may differ from simulated information, results, or performance being presented. For more information about Valuentum and the products and services it offers, please contact us at info@valuentum.com.